Early data from first patient in phase Ib/II study of leronlimab in CCR5-poisitive mTNBC Dec. 4, 2019
MAC-545496, a potent inhibitor that attenuates virulence and reverses antibiotic resistance in MRSA Dec. 4, 2019
OSE-127 phase I data pave way for phase II studies in ulcerative colitis and Sjogren's syndrome Dec. 3, 2019
RSS